Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5732_Библиотеки_им_академика_М_И_Перельмана
.pdf
Leishmaniasis
Organic Compounds to Combat Neglected Tropical Diseases 111
[23] Thakur, C. P.; Kumar, M.; Pandey, A. K. Comparison of regimes of treatment of antimony-
resistant kala-azar patients: a randomized study. Am. J. Trop. Med. Hyg., 1991, 45, 435-
441.
[24] Jha, S. N.; Singh, N. K.; Jha, T. K. Changing response to diamidine compounds in cases of
kala-azar unresponsive to antimonial. J. Assoc. Physicians India, 1991, 39, 314-316.
[25] Berman, J. J. Treatment of leishmaniasis with miltefosine : 2008 status. Expert Opin. Drug.
Metab. Toxicol. 2008, 4, 1209-1216.
[26] Berman, J. D. Development of miltefosine for the leishmaniases. Mini-Rev. Med. Chem.,
2006, 6, 145-151.
[27] Sundar, S.; Jha, T. K.; Thakur, C. P.; Engel, J.; Sindermann, H.; Fischer, C.; Junge, K.;
Bryceson, A.; Berman, J. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J.
Med., 2002, 347, 1739-1746.
[28] Thakur, C. P.; Kanyok, T. P.; Pandey, A. K.; Sinha, G. P.; Zaniewski, A. E.; Houlihan, H.
H.; Olliaro, P. A prospective randomized, comparative, open-label trial of the safety and
efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium
stibogluconate alone for the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med.
Hyg., 2000, 94, 429-431.
[29] Sundar, S.; Jha, T. K.; Thakur, C. P.; Sinha, P. K.; Bhattacharya, S. K. Injectable
Paromomycin for Visceral Leishmaniasis in India. N. Engl. J. Med. 2007, 356, 2571-2581.
[30] Sherwood, J. A.; Gachihi, G. S.; Muigai, R. K.; Skillman, D. R.; Mugo, M.; Rashid, J. R.;
Wasunna, K. M.; Were, J. B.; Kasili, S. K.; Mbugua, J. M. Phase 2 efficacy trial of an oral
8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin. Infect. Dis.,
1994, 19, 1034-1039.
[31]
Yeates, C. Sitamaquine (GlaxoSmithKline/Walter Reed Army Institute). Curr Opin
Investig Drugs 2002, 3, 1446-1452.
[32] Wasunna, M. K.; Rashid, J. R.; Mbu i, J.; Kirig i, G.; Kinoti, D.; Lodenyo, H.; Felton, J. M.;
Sabin, A. J.; Albert, M. J.; Horton, J. A phase II dose-increasing study of sitamaquine for
the treatment of visceral leishmaniasis in Kenya. Am. J. Trop. Med. Hyg., 2005, 73, 871-
876.
[33] Jha, T. K.; Sundar, S.; Thakur, C. P.; Felton, J. M.; Sabin, A. J.; Horton, Am. J. Trop. Med.
Hyg. 2005, 73, 1005-1011.
[34] Al-Abdely, H. M.; Graybill, J. R.; Loebenberg, D.; Melby, P. C. Efficacy of the Triazole
SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental
Murine Cutaneous and Visceral Leishmaniases. Antimicrob Agents Chemother., 1999, 43,
2910-2914.
[35] Bakunov, S. A.; Bakunova, S. M.; Wenzler, T.; Ghebru, M.; Werbovetz, K. A.; Brun, R.;
Tidwell, R. R. Synthesis and Antiprotozoal Activity of Cationic 1,4-Diphenyl-1H-1,2,3-
triazoles. J. Med. Chem. , 2010, 53, 254-272.
[36] Patil, V.; Guerrant, W.; Chen, P. C.; Gryder, B.; Benicewicz, D. B.; Khan, S. I.; Tekwani,
B. L.; Oyelere, A. K. Antimalarial and antileishmanial activities of histone deacetylase
inhibitors with triazole-linked cap group. Bioorg. Med. Chem., 2010, 18, 415-425.
[37] Ferreira, S. B.; Costa, M. S.; Boechat, N.; S. Bezerra, R. J.; Genestra, M. S.; Canto-
Cavalheiro, M. M.; Kover, W. B.; Ferreira, V. F. Synthesis and evaluation of new
difluoromethyl azoles as antileishmanial agents. Eur. J. Med. Chem., 2007, 42, 1388-1395.
[38] Hussain, T.; Siddiqui, H. L.; Zia-ur-Rehman, M.; Yasinzai, M. M.; Parvez, M. Anti-
oxidant, anti-fungal and anti-leishmanial activities of novel 3-[4-(1H-imidazol-1-yl)
phenyl]prop-2-en-1-ones. Eur. J. Med. Chem., 2009,
44, 4654-4660.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
112 Organic Compounds to Combat Neglected Tropical Diseases Boechat and Pinheiro
[39] Bhandari, K.; Srinivas, N.; Marrapu, V. K.; Verma, A.; Srivastava, S.; Gupta, S. Synthesis
of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Bioorg. Med. Chem. Lett., 2010, 20, 291-293.
[40] Srinivas, N.; Palne, S.; Nishi, Gupta, S.; Bhandari, K. Aryloxy cyclohexyl imidazoles: A
novel class of antileishmanial agents. Bioorg. Med. Chem. Lett., 2009, 19, 324-327.
[41] Boiani, M.; Boiani, L.; Denicola, A.; Ortiz, S. T.; Serna, E.; Bilbao, N. V.; Sanabria, L.;
Yaluff, G.; Nakayama, H.; Arias, A. R.; Vega, C.; Rolan, M.; Gomez-Barrio, A.; Cerecetto,
H.; Gonzalez, M. 2H-Benzimidazole 1,3-Dioxide Derivatives: A New Family of Water-
Soluble Anti-Trypanosomatid Agents. J. Med. Chem. 2006, 49, 3215-3224.
[42] Boiani, M.; Boiani, L.; Merlino, A.; Hernandez, P.; Chidichimo, A.; Cazzulo, J. J.;
Cerecetto, H.; Gonzalez, M. Second generation of 2H-benzimidazole 1,3-dioxide
derivatives as anti-trypanosomatid agents: Synthesis, biological evaluation, and mode of
action studies. Eur. J. Med. Chem., 2009, 44, 4426-4433.
[43] Marrapu, V. K.; Mittal, M.; Shivahare, R.; Gupta, S.; Bhandari, K. Synthesis and
evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Eur. J. Med.
Chem., 2011, 46, 1694-1700.
[44] Marrapu, V. K.; Srinivas, N.; Mittal, M.; Shakya, N.; Gupta, S.; Bhandari, K. Design and
synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as
antileishmanial agents. Bioorg. Med. Chem. Lett., 2011, 21, 1407-1410.
[45] Santos, M. S.; Gomes, A. O.; Bernardino, A. M. R; Souza, M. C.; Khan, M. A.; Brito, M.
A.; Castro, H. C.; Abreu, P. A.; Rodrigues, C. R.; Leo, R. M. M.; Leon, L. L.; Canto-
Cavalheiro, M. M. J. Braz. Chem. Soc., 2011, 22, 352-358.
[46] Santos, M. S.; Oliveira, M. L.V.; Bernardino, A. M. R.; Leo, R. M.; Amaral, V. F.;
Carvalho, F. T.; Leon, L. L.; Canto-Cavalheiro, M. M. Synthesis and antileishmanial
evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives. Bioorg.
Med. Chem. Lett., 2011, 21, 7451-7454.
[47] Kuettel, S.; Zambon, A.; Kaiser, M.; Brun, R.; Scapozza, L.; Perozzo, R. Synthesis and
Evaluation of Antiparasitic Activities of New 4-[5-(4-Phenoxyphenyl)-2H-pyrazol-3-
yl]morpholine Derivatives. J. Med. Chem., 2007, 50, 5833-5839.
[48] Bernardino, A. M. R.; Gomes, A. O.; Charret, K. S.; Freitas, A. C. C.; Machado, G. M. C.;
Canto-Cavalheiro, M. M.; Leon, L. L.; Amaral, V. F. Synthesis and leishmanicidal
activities of 1-(4-X-phenyl)- N′-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides.
Eur. J. Med. Chem., 2006, 41, 80-87.
[49] Tahghighi, A.; Marznaki, F. R.; Kobarfard, F.; Dastmalchi, S.; Mojarrad, J. S.; Razmi, S.;
Ardestani, S. K.; Emami, S.; Shafiee, A.; Foroumadi, A. Synthesis and antileishmanial
activity of novel 5-(5-nitrofuran -2-yl)-1,3,4-thiadiazoles with piperazinyl-linked
benzamidine substituents. Eur. J. Med. Chem., 2011, 46, 2602-2608.
[50] Poorrajab, F.; Ardestani, S. K.; Emami, S.; Behrouzi-Fardmoghadam, M.; Shafiee, A.;
Foroumadi, A. Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: Synthesis
and in vitro biological evaluation. Eur. J. Med. Chem., 2009, 44, 1758-1762.
[51] Behrouzi-Fardmoghadam, M.; Poorrajab, F.; Ardestani, S. K.; Emami, S.; Shafiee, A.;
Foroumadi, A. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran -2-yl)-
1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-
aroylpiperazines. Bioorg. Med. Chem., 2008, 16, 4509-4515.
[52] Poorrajab, F.; Ardestani, S. K.; Foroumadi, A.; Emami, S.; Kariminia, A.; Behrouzi-
Fardmoghadam, M.; Shafiee, A. Selective leishmanicidal effect of 1,3,4-thiadiazole
Leishmaniasis
Organic Compounds to Combat Neglected Tropical Diseases 113
derivatives and possible mechanism of action against Leishmania species. Exp. Parasitol.,
2009, 121, 323-330.
[53] Rodrigues, R. F.; Silva, E. F.; Echevarria, A.; Fajardo-Bonin, R.; Amaral, V. F.; Leon, L.
L.; Canto-Cavalheiro, M. M. A comparative study of mesoionic compounds in Leishmania
sp. and toxicity evaluation. Eur. J. Med. Chem., 2007, 42, 1039-1043.
[54] Boiani, L.; Aguirre, G.; González, M.; Cerecetto, H.; Chidichimo, A.; Cazzulo, J. J.;
Bertinaria, M.; Guglielmo, S. Furoxan-, alkylnitrate-derivatives and related compounds as
anti-trypanosomatid agents: Mechanism of action studies. Bioorg. Med. Chem., 2008, 16,
7900-7907.
[55] Reimão, J. Q.; Scotti, M. T.; Tempone, A. G. Anti-leishmanial and anti-trypanosomal
activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship
study. Bioorg. Med. Chem., 2010, 18, 8044-8053.
[56] Pandey, S.; Suryawanshi, S. N.; Nishi; Goyal, N.; Gupta, S. Chemotherapy of
leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives.
Eur. J. Med. Chem., 2007, 42, 669-674.
[57] Pandey, V. P.; Bisht, S. S.; Mishra, M.; Kumar, A.; Siddiqi, M. I.; Verma, A.; Mittal, M.;
Sane, S. A.; Gupta, S.; Tripathi, R. P.; Synthesis and molecular docking studies of 1-
phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agen ts. Eur. J. Med. Chem.
2010, 45, 2381-2388.
[58] Musonda, C. C.; Whitlock, G. A.; Witty, M. J.; Brun, R.; Kaiser, M. Synthesis and
evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial
activity Bioorg. Med. Chem. Lett., 2009, 19, 401-405.
[59] Suryawanshi, S. N.; Bhat, B.A.; Pandey, S.; Chandra, N.; Gupta, S. Chemotherapy of
leishmaniasis. Part VII: Synthesis and bioevaluation of substituted terpenyl pyrimidines.
Eur. J. Med. Chem., 2007, 42
, 1211-1217.
[60] Suryawanshi, S. N.; Pandey, S.; Rashmirathi; Bhatt, B. A.; Gupta, S. Chemotherapy of
leishmaniasis Part VI: Synthesis and bioevaluation of some novel terpenyl S,N- and N,N-
acetals. Eur. J. Med. Chem., 2007, 42, 511-516.
[61] Pandey, S.; Suryawanshi, S. N.; Gupta, S.; Srivastava, V. M. L. Synthesis and
antileishmanial profile of some novel terpenyl pyrimidines. Eur. J. Med. Chem., 2004, 39,
969-973.
[62] Sunduru, N.; Nishi, Palne, S.; Chauhan, P. M. S.; Gupta, S. Synthesis and antileishmanial
activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Eur. J. Med. Chem.,
2009, 44, 2473-2481.
[63] Fan, X.; Feng, D.; Qu, Y.; Zhang, X.; Wang, J.; Loiseau, P. M.; Andrei, G.; Snoeck, R.; De
Clercq, E. Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran
and their hybrids with nucleoside as potential antiviral and antileishmanial agents. Bioorg.
Med. Chem. Lett., 2010, 20, 809-813.
[64] Tempone, A. G.; Silva, A. C. M. P.; Brandt, C. A.; Martinez, F. S.; Borborema, S. E. T.;
Silveira, M. A. B.; Andrade Jr, H. F. Synthesis and Antileishmanial Activities of Novel 3-
Substituted Quinolines. Antimicrob. Agents Chemother., 2005, 49, 1076-1080.
[65] Guglielmo, S.; Bertinaria, M.; Rolando, B.; Crosetti, M.; Fruttero, R.; Yardley, V.; Croft, S.
L.; Gasco, A. A new series of amodiaquine analogues modified in the basic side chain with
in vitro antileishmanial and antiplasmodial activity. Eur. J. Med. Chem., 2009, 44, 5071-
5079.
[66] Kaur, K.; Patel, S. R.; Patil, P.; Jain, M.; Khan, S. I.; Jacob, M. R.; Ganesan, S.; Tekwani,
B. L.; Jain, R. Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
114 Organic Compounds to Combat Neglected Tropical Diseases Boechat and Pinheiro
methemoglobin (MetHB) formation activities of new 8-quinolinamines. Bioorg. Med.
Chem., 2007, 15, 915-930.
[67] Khan, M. O. F.; Levi, M. S.; Tekwani, B. L.; Wilson, N. H.; Borne, R. F. Synthesis of
isoquinuclidine analogs of chloroquine: Antimalarial and antileishmania l activity. Bioorg.
Med. Chem., 2007, 15, 3919-3925.
[68] Silva, L. E.; Joussef, A. C.; Pacheco, L. K.; Silva, D. G.; Steindel, M.; Rebelo, R. A.
Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-
quinolin-8-yl-arylsulfonamides Bioorg. Med. Chem., 2007, 15, 7553-7560.
[69] Pagliero, R. J.; Lusvarghi, S.; Pierini, A. B.; Brun, R.; Mazzieri, M. R. Synthesis,
stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-
methyl-1,2,3,4-tetrahydroquinolines. Bioorg. Med. Chem., 2010, 18, 142-150.
[70] Palit, P.; Paira, P.; Hazra, A.; Banerjee, S.; Gupta, A. D.; Dastidar, S. G.; Mondal, N. B.
Phase transfer catalyzed synthesis of bis-quinolines: Antileishmanial activity in
experimental visceral leishmaniasis and in vitro antibacterial evaluation. Eur. J. Med.
Chem., 2009, 44, 845-853.
[71] Zhu, X. Y.; Mardenborough, L. G.; Li, S.; Khan, A.; Zhang, W.; Fan, P.; Jacob, M.; Khan,
S.; Walker, L.; Ablordeppey, S. Y. Synthesis and evaluation of isosteres of N-methyl
indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents. Bioorg. Med. Chem.
2007, 15, 686-695.
[72] Ponte-Sucre, A.; Gulder, T.; Wegehaupt, A.; Albert, C.; Rikanovic, C.; Schaeflein, L.;
Frank, A.; Schultheis, M.; Unger, M.; Holzgrabe, U.; Bringmann, G.; Moll, H. Structure-
Activity Relationship and Studies on the Molecular Mechanism of Leishmanicidal N,C-
Coupled Arylisoquinolinium Salts. J. Med. Chem., 2009, 52, 626-636.
[73]
Kumar, S.; Shakya, N.; Gupta, S.; Sarkar, J.; Sahu, D. P. Synthesis and biological
evaluation of novel 4-(hetero) aryl-2-piperazin o quinazolines as anti-leishmanial and anti-
proliferative agents. Bioorg. Med. Chem. Lett., 2009, 19, 2542-2545.
[74] Agarwal, K. C.; Sharma, V.; Shakya, N.; Gupta, S. Design and synthesis of novel
substituted quinazoline derivatives as antileishmanial agents. Bioorg. Med. Chem. Lett.,
2009, 19, 5474-5477.
[75] Guillon, J.; Forfar, I.; Mamani-Matsuda, M.; Desplat, V.; Saliège, M.; Thiolat, D.; Massip,
S.; Tabourier, A.; Léger, J.; Dufaure, B.; Haumont, G.; Jarry, C.; Mossalayi, D. Synthesis,
analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-
a]quinoxalines as antileishmanial agents. Bioorg. Med. Chem., 2007, 15, 194-210.
[76] Benitez, D.; Cabrera, M.; Hernandez, P.; Boiani, L.; Lavaggi, M. L.; Di Maio, R.; Yaluff,
G.; Serna, E.; Torres, S.; Ferreira, M. E.; Bilbao, N. V.; Torres, E.; Perez-Silanes, S.;
Solano, B.; Moreno, E.; Aldana, I.; Cerain, A. L.; Cerecetto, H.; Gonzalez, M.; Monge, A.
3-Trifluoromethylquinoxaline N,N’-Dioxides as Anti-Trypanosomatid Agents.
Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action Studies. J. Med.
Chem. 2011, 54, 3624-3636.
[77] Barea, C.; Pabón, A.; Castillo, D.; Zimic, M.; Quiliano, M.; Galiano, S.; Pérez-Silanes, S.;
Monge, A.; Deharo, E.; Aldana, I. New salicylamide and sulfonamide derivatives of
quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities. Bioorg. Med.
Chem. Lett., 2011, 21, 4498-4502.
[78] Chakrabarti, G.; Basu, A.; Manna, P. P.; Mahato, S. B.; Mandal, N. B.; Bandyopadhyay, S.
Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and
amastigotes in vitro and are effective in treating murine visceral leishmaniasis. J.
Antimicrob. Chemother., 1999, 43, 359-366.
Leishmaniasis
Organic Compounds to Combat Neglected Tropical Diseases 115
[79] Singh, U. S.; Shankar, R.; Kumar, A.; Trivedi, R.; Chattopadhyay, N.; Shakya, N.;. Palne,
S; Gupta, S.; Hajela, K. Synthesis and biological evaluation of indolyl bisphosphonates as
anti-bone resorptive and anti-leishmanial agents. Bioorg. Med. Chem., 2008, 16, 8482-
8491.
[80] Porwal, S.; Chauhan, S. S.; Chauhan, P. M. S.; Shakya, N.; Verma, A.; Gupta, S. Discovery
of Novel Antileishmanial Agents in an Attempt to Synthesize Pentamidine-Aplysinopsin
Hybrid Molecule. J. Med. Chem., 2009, 52, 5793-5802.
[81] Barbaras, D.; Kaiser, M.; Brun, R.; Gademann, K. Potent and selective antiplasmodial
activity of the cyanobacterial alkaloid nostocarboline and its dimers. Bioorg. Med. Chem.
Lett., 2008, 18, 4413-4415.
[82] Bonazzi, S.; Barbaras, D.; Patiny, L.; Scopelliti, R.; Schneider, P.; Cole, S. T.; Kaiser, M.;
Brun, R.; Gademann, K. Antimalarial and antitubercular nostocarboline and eudistomin
derivatives: Synthesis, in vitro and in vivo biological evaluation. Bioorg. Med. Chem.,
2010, 18, 1464-1476.
[83] Chauhan, S. S.; Gupta, L.; Mittal, M.; Vishwakarma, P.; Gupta, S.; Chauhan, P. M. S.
Synthesis and biological evaluation of indolyl glyoxylamides as a new class of
antileishmanial agents. Bioorg. Med. Chem. Lett., 2010, 20, 6191-6194.
[84] Kumar, R.; Khan, S.; Verma, A.; Srivastava, S.; Viswakarma, P.; Gupta, S.; Meena, S.;
Singh, N.; Sarkar, J.; Chauhan, P. M. S. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-
tetrahydro-1H-β carbolinesas antileishmanial agents. Eur. J. Med. Chem. 2010, 45, 3274-
3280.
[85] Gupta, L.; Sunduru, N.; Verma, A.; Srivastava, S.; Gupta, S.; Goyal, N.; Chauhan, P. M. S.
Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-
triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-p yrimidines against Leishmania donovani.
Eur. J. Med. Chem. 2010, 45, 2359-2365.
[86] Bouchikhi, F.; Anizon, F.; Brun, R.; Moreau, P. Bioorg. Med. Chem., 2011, 21, 6319-6321.
[87] Braga, F. G.; Coimbra, E. S.; Matos, M. O.; Carmo, A. M. L.; Cancio, M. D.; Silva, A. D.
Synthesis and biological evaluation of some 6-substituted purines. Eur. J. Med. Chem.,
2007, 42, 530-537.
[88] Jorda, R.; Sacerdoti-Sierra, N.; Voller, J.; Havlicek, L.; Kracalikova, K.; Nowicki, M. W.;
Nasereddin, A.; Kryštof, V.; Strnad, M.; Walkinshaw, M. D.; Jaffe, C. L. Anti-leishmanial
activity of disubstituted purines and related pyrazolo[4,3-d]pyrimidines. Bioorg. Med.
Chem. Lett., 2011, 21, 4233-4237.
[89] Mello, H.; Echevarria, A.; Bernardino, A. M.; Canto-Cavalheiro, M.; Leon, L. L.
Antileishmanial Pyrazolopyridine Derivatives: Synthesis and Structure-Activity
Relationship Analysis. J. Med. Chem. 2004, 47, 5427-5432.
[90] Pinheiro, L. C. S.; Borges, J. C.; Santos, M. S.; Ferreira, V. F.; Bernardino, A. M. R.;
Tonioni, R.; Sathler, P. C.; Castro, H. C.; Santos, D. O.; Nascimento, S. B.; Bourguignon,
S. C.; Magalhães, U. O.; Cabral, L.; Rodrigues, C. R. Journal of Microbiology and
Antimicrobials 2012, 4(1), 32-39.
[91] Aponte, J. C.; Vaisberg, A. J.; Castillo, D.; Gonzalez, G.; Estevez, Y.; Arevalo, J.;
Quiliano, M.; Zimic, M.; Verástegui, M.; Málaga, E.; Gilman, R. H.; Bustamante, J. M.;
Tarleton, R. L.; Wang, Y.; Franzblau, S. G.; Pauli, G. F.; Sauvain, M.; Hammond, G. B.
Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of
tetrahydrobenzothienopyrimidines. Bioorg. Med. Chem., 2010, 18, 2880-2886.
[92] Torres-Gómez, H.; Hernández-Núñez, E.; León-Rivera, I.; Guerrero-Alvarez, J.; Cedillo-
Rivera, R.; Moo-Puc, R.; Argotte-Ramos, R.; Rodríguez-Gutiérrez, M. C.; Chan-Bacab, M.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
116 Organic Compounds to Combat Neglected Tropical Diseases Boechat and Pinheiro
J.; Navarrete-Vázquez, G. Design, synthesis and in vitro antiprotozoal activity of
benzimidazolepentamidine hybrids. Bioorg. Med. Chem. Lett., 2008, 18, 3147-3151.
[93] Yang, M.; Arai, C.; Md., A. B.; Lu, J.;. Ge, J.-F.; Pudhom, K.; Takasu, K.; Kasai, K.;
Kaiser, M.; Brun, R.; Yardley, V; Itoh, I.; Ihara, M. Fluorinated Rhodacyanine (SJL-01)
Possessing High Efficacy for Visceral Leishmaniasis (VL). J. Med. Chem., 2010, 53, 368-
373.
[94] Castro, D.; Boiani, L.; Benitez, D.; Hernandez, P.; Merlino, A.; Gil, C.; Olea-Azar, C.;
Gonzalez, M.; Cerecetto, H.; Porcal, W. Anti-trypanosomatid benzofuroxans and
deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine,
biological evaluation and mechanism of action studies. Eur. J. Med. Chem. 2009, 44, 5055-
5065.
[95] Tipparaju, S. K.; Joyasawal, S.; Pieroni, M.; Kaiser, M.; Brun, R.; Kozikowski, A. P. In
Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-
[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole -4-carboxylic acid (A-33853)
and Its Analogues: Discovery of N-(2-Benzoxazol-2-ylphenyl)benzamides as Novel
Antileishmanial Chemotypes. J. Med. Chem., 2008, 51, 7344-7347.
[96] Navarrete-Vazquez, G.; Chávez-Silva, F.; Argotte-Ramos, R.; Rodríguez-Gutiérrez, M. C.;
Chan-Bacab, M. J.; Cedillo-Rivera, R.; Moo-Puc, R.; Hernández-Nuñez, E. Synthesis of
benzologues of Nitazoxanide and Tizoxanide: A comparative study of their in vitro broad-
spectrum antiprotozoal activity. Bioorg. Med. Chem. Lett., 2011, 21, 3168-3171.
[97] Di Giorgio, C.; Shimi, K.; Boyer, G.; Delmas, F.; Galy, J.-P. Synthesis and antileishmanial
activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of
proflavine. Eur. J. Med. Chem., 2007, 42, 1277-1284.
[98] Pierson, J.-T.; Dumètre, A.; Hutter, S.; Delmas, F.; Laget, M.; Finet, J.-P.; Azas, N.;
Combes, S. Synthesis and antiprotozoal activity of 4-arylcoumarins. Eur. J. Med. Chem.,
2010, 45, 864-869.
[99]
Giddens, A. C.; Nielsen, L.; Boshoff, H. I.; Tasdemir, D.; Perozzo, R.; Kaiser, M.; Wang,
F.; Sacchettini, J. C.; Copp, B. R. Natural product inhibitors of fatty acid biosynthesis:
synthesis of the marine microbial metabolites pseudopyronines A and B and evaluation of
their anti-infective activities. Tetrahedron, 2008, 64, 1242-1249.
[100] Palma, A.; Yépes, A. F.; Leal, S. M.; Coronado, C. A.; Escobar, P. Synthesis and in vitro
activity of new tetrahydronaphtho[1,2-b]azepine derivatives against Trypanosoma cruzi and
Leishmania chagasi parasites. Bioorg. Med. Chem. Lett., 2009, 19, 2360-2363.
[101] Gómez-Ayala, S.; Castrillón, J. A.; Palma, A.; Leal, S. M.; Escobar, P.; Bahsas, A.
Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma
cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.
Bioorg. Med. Chem., 2010, 18, 4721-4739.
[102] Reichwald, C.; Shimony, O.; Dunkel, U.; Sacerdoti-Sierra, N.; Jaffe, C. L.; Kunick, C. 2-
(3-Aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: A New Antileishmanial Chemotype. J.
Med. Chem. 2008, 51, 659-665.
[103] Kelly, J. X.; Ignatushchenko, M. V.; Bouwer, H. G.; Peyton, D. H.; Hinrich s, D. J.; Winter,
R. W.; Riscoe, M. Antileishmanial drug development : exploitation of parasite heme
dependency. Mol. Biochem. Parasitol., 2003, 126, 43-49.
[104] Boechat, N.; Bastos, M. M Gomes, A. T. P. C.; Neves, M. G. P. M. S.; Cavaleiro, J. A. S. O
Uso de Porfirinas em Terapia Fotodinâmica no Tratamento da Leishmaniose Cutânea. Rev.
Virtual Quim., 2012, 4 (3), 257-267.
Leishmaniasis
Organic Compounds to Combat Neglected Tropical Diseases 117
[105] Bastos, M. M.; Gomes, A. T. P. C.; Neves, M. G. P. M. S.; Silva, A. M. S.; Santos-Filho,
O.A.; Boechat, N.; Cavaleiro, J. A. S. Synthesis of β-Substituted Porphyrin Derivatives
Containing Heterocyclic Moieties as Potential Photosensitizers Against Cutaneous
Leishmaniasis. Eur. J. Org. Chem., 2013, 8, 1485-1493.
[106] Morgenthaler, J. B.; Peters, S. J.; Cedeño, D. L.; Constantino, M. H.; Edwards, K. A.;
Kamowski, E. M.; Passini, J. C. Butkus, B. E.; Young, A. M.; Lash, T. D.; Jones, M. A.
Carbaporphyrin ketals as potential agents for a new photodynamic therapy treatment of
leishmaniasis. Bioorg. Med. Chem., 2008, 16, 7033-7038.
[107] Stephens, C. E.; Tanious, F.; Kim, S.; Wilson, W. D.; Schell, W. A.; Perfect, J. R.;
Franzblau, S. G.; Boykin, D. W. Diguanidino and “Reversed” Diamidino 2,5-Diarylfurans
as Antimicrobial Agents. J. Med. Chem., 2001, 44, 1741-1748.
[108] Ansede, J. H.; Anbazhagan, M.; Brun, R.; Easterbrook, J. D.; Hall, J. E.; Boykin, D. W. O-
Alkoxyamidine prodrugs of furamidine: in vitro transp ort and microsomal metabolism as
indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense
infection. J. Med. Chem., 2004, 47, 4335-4338.
[109] Das, B. P.; Boykin, D. W. Synthesis and antiprotozoal activity of 2,5-bis(4-
guanylphenyl)furans. J. Med. Chem., 1977, 20, 531-536.
[110] Werbovetz, K. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Curr. Opin. Investig. Drugs., 2006, 7, 147-157.
[111] Silva, C. F.; Batista, M. M.; Batista, D. G. J.; Souza, E. M.; Silva, P. B.; Oliveira, G. M.;
Meuser, A.-S.; Shareef, A.; Boykin, D. W.; Soeiro, M. N. C. In Vitro and In Vivo Studies of
the Trypanocidal Activity of a Diarylthiophene Diamidine against Trypanosoma cruzi,
Antimicrob Agents Chemother., 2008, 52, 3307-3314.
[112] Bell, C. A.; Hall, J. E.; Kyle, D. E.; Grogl, M.; Ohemeng, K. A.; Allen, M. A.; Tidwell, R.
R. Structure-activity relationships of analogs of pentamidine against Plasmodium
falciparum
and Leishmania mexicana amazonensis. Antimicrob. Agents Chemother., 1990,
34, 1381-1386.
[113] Bakunova, S. M.; Bakunov, S. A.; Patrick, D. A.; Kumar, E. V. K. S.; Ohemeng, K. A.;
Bridges, A. S.; Wenzler, T.; Barszcz, T.; Jones, S. K.; Werbovetz, K. A.; Brun, R.; Tidwell,
R. R. Structure-Activity Study of Pentamidine Analogues as Antiprotozoal A gents. J. Med.
Chem., 2009, 52, 2016-2035.
[114] Bakunova, S. M.; Bakunov, S. A.; Wenzler, T.; Barszcz, T.; Werbovetz, K. A.; Brun, R.;
Tidwell, R. R. Synthesis and Antiprotozoal Activity of Pyridyl Analogues of Pentamidine.
J. Med. Chem., 2009, 52, 4657-4667.
[115] Bakunov, S. A.; Bakunova, S. M.; Bridges, A. S.; Wenzler, T.; Barszcz, T.; Werbovetz, K.
A.; Brun, R.; Tidwell, R. R. Synthesis and Antiprotozoal Properties of Pentamidine
Congeners Bearing the Benzofuran Motif. J. Med. Chem., 2009, 52, 5763-5767.
[116] Bakunova, S. M.; Bakunov, S. A.; Wenzler, T.; Barszcz, T.; Werbovetz, K. A.; Brun, R.;
Hall, J. E.; Tidwell, R. R. Synthesis and in Vitro Antiprotozoal Activity of Bisbenzofuran
Cations. J. Med. Chem. 2007, 50, 5807-5823.
[117] Bakunov, S. A.; Bakunova, S. M.; Wenzler, T.; Barszcz, T.; Werbovetz, K. A.; Brun, R.;
Tidwell, R. R. Synthesis and Antiprotozoal Activity of Cationic 2-Phenylbenzofurans. J.
Med. Chem. 2008, 51, 6927-6944.
[118] Patrick, D. A.; Bakunov, S. A.; Bakunova, S. M.; Kumar, E. V. K. S. ; Chen, H.; Jones, S.
K.; Wenzler, T.; Barzcz, T.; Werbovetz, K. A. Brun, R.; Tidwell, R. R. Synthesis and
antiprotozoal activities of dicationic bis(phenoxymethyl)benzenes,
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
118 Organic Compounds to Combat Neglected Tropical Diseases Boechat and Pinheiro
bis(phenoxymethyl)naphthalenes, and bis(benzyloxy)naphthalenes. Eur. J. Med. Chem.,
2009,44, 3543-3551.
[119] Hu, L.; Arafa, R. K.; Ismail, M. A.; Wenzler, T.; Brun, R.; Munde, M.; Wilson, W. D.;
Nzimiro, S.; Samyesudhas, S.; Werbovetz, K. A.; Boykin, D. W. Azaterphenyl diamidines
as antileishmanial agents. Bioorg. Med. Chem. Lett., 2008, 18, 247-251.
[120] Bouhlel, A.; Curti, C.; Dumètre, A.; Laget, M.; Crozet, M. D.; Azas, N.; Vanelle, P.
Synthesis and evaluation of original amidoximes as antileishmanial agents. Bioorg. Med.
Chem., 2010, 18, 7310-7320.
[121] Dea-Ayuela, M. A.; Castillo, E.; Gonzalez-Alvarez, M.; Vega, C.; Rolón, M.; Bolás-
Fernández, F.; Borrás, J.; González-Rosende, M. E. In vivo and in vitro anti-leishmanial
activities of 4-nitro-N-pyrimidinand N-pyrazin-2-ylbenzenesulfonamides, and N
2
-(4-
nitrophenyl)-N
1
-Propylglycinamide. Bioorg. Med. Chem., 2009, 17, 7449-7456.
[122] Rao, G. k.; Kotnal, R. B.; Pai, P. N. S. Synthesis an d Evaluation of N’-((Substitu ed Phenyl)
Methylidene)-2-(3-Methyl-2-oxoquinoxalin-1(2H)-yl) Acetohydrazide for Possible
Antibacterial and Antifungal Activities. Int. J. Biol. Chem., 2009, 3, 71-77.
[123] Mohareb, R. M.; El-Arab, E. E.; El-Sharkawy, K. A. The Reaction of Cyanoacetic Acid
Hydrazide with 2-Acetylfuran: Synthesis of Coumarin, Pyridine, Thiophene and Thiazole
Derivatives with Potential Antimicrobial Activities. Sci. Pharm., 2009, 77, 355-366.
[124] Rando, D. G.; Avery, M. A.; Tekwani, B. L.; Khan, S. I.; Ferreira, E. I. Antileish manial
activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides. Bioorg. Med. Chem.,
2008, 16, 6724-6731.
[125] Di Carlo, G.; Mascolo, N.; lzzo, A. A.; Capasso, F. Flavonoids: Old and New Aspects of a
Class of Natural Therapeutic Drugs. Life Sciences, 1999, 65, 337-353.
[126] Dhar, D. N. The Chemistry of Chalcones and Related Compounds., Wiley, New York,
1981.
[127] Dimmock, J. R.; Elias, D. W.; Beazely, M. A.; Kandepu, N. M. Bioactivities of Chalcones.
Curr. Med. Chem., 1999, 6, 1125-1150.
[128] Go, M. L.; Wu, X.; Liu, X. L. Chalcones : An Update on Cytotoxic and Chemoprotective
Properties. Curr. Med. Chem., 2005, 12, 483-499.
[129] Bello, M. L.; Chiaradi, L. D.; Dias, L. R. S.; Pacheco, L. K.; Stumpf, T. R.; Mascarello, A.;
Steindel, M.; Yunes, R. A.; Castro, H. C.; Nunes, R. J.; Rodrigues, C. R. Trimethoxy-
chalcone derivatives inhibit growth of Leishmania braziliensis: Synthesis, biological
evaluation, molecular modeling and structure-activity relationship (SAR). Bioorg. Med.
Chem. 2011, 19, 5046-5052.
[130] Andrighetti-Frhner, C. R.; Oliveira, K. N.; Gaspar-Silva, D.; Pacheco, L. K.; Joussef, A. C.;
Steindel, M.; Simões, C. M. O.; Souza, A. M. T.; Magalhaes, U. O.; Afonso, I. F.;
Rodrigues, C. R.; Nunes, R. J.; Castro, H. C. Synthesis, biological evaluation and SAR of
sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity. Eur. J.
Med. Chem., 2009, 44, 755-763.
[131] Souza, A. M. T.; Castro, H. C.; Brito, M. A.; Andrighetti-Frohner, C. R.; Magalhães, U.;
Oliveira, K. N.; Gaspar-Silva, D.; Pacheco, L. K.; Joussef, A. C.; Steindel, M.; Simões, C.
M. O.; Santos, D. O.; Albuquerque, M. G.; Rodrigues, C. R.; Nunes, R. J. Leishmania
amazonensis Growth Inhibitors: Biological and Theoretical Features of Sulfonamide 4-
Methoxychalcone Derivatives. Curr. Micróbiol., 2009, 59, 374-379.
[132] Quintin, J.; Desrivot, J.; Thoret, S.; Le Menez, P.; Cresteil, T.; Lewin, G. Synthesis and
biological evaluation of a series of tangeretin -derived chalcones. Bioorg. Med. Chem. Lett.,
2009, 19, 167-169.
Leishmaniasis
Organic Compounds to Combat Neglected Tropical Diseases 119
[133] Reichwald, C.; Shimony, O.; Sacerdoti-Sierra, N.; Jaffe, C. L.; Kunick, C. A new Heck
reaction modification using ketone Mannich bases as enone precursors: Parallel synthesis
of anti-leishmanial chalcones. Bioorg. Med. Chem. Lett, 2008, 18, 1985-1989.
[134] Suryawanshi, S.N.; Chandra, N.; Kumar, P.; Porwal, J.; Gupta, S. Chemotherapy of
leishmaniasis part-VIII: Synthesis and bioevaluation of novel chalcones. Eur. J. Med.
Chem., 2008, 43, 2473-2478.
[135] Nazarian, Z.; Emami, S.; Heydari, S.; Ardestani, S. K.; Nakhjiri, M.; Poorrajab, F.; Shafiee,
A.; Foroumadi, A. Novel antileishmanial chalconoids: Synthesis and biological activity of
1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones. Eur. J. Med. Chem., 2010, 45, 1424-
1429.
[136] Aponte, J. C.; Castillo, D.; Estevez, Y.; Gonzalez, G.; Arevalo, J.; Hammond, G. B.;
Sauvain, M. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic
chalcones. Bioorg. Med. Chem. Lett., 2010, 20, 100-103.
[137] Bello, M. L.; Chiaradia, L. D.; Dias, L. R. S.; Pacheco, L. K.; Stumpf, T. R.; Mascarello,
A.; Steindel, M.; Yunes, R. A.; Castro, H. C.; Nunes, R. J.; Rodrigues, C. R. Trimethoxy-
chalcone derivatives inhibit growth of Leishmania braziliensis: Synthesis, biological
evaluation, molecular modeling and structure–activity relationship (SAR). Bioorg. Med.
Chem., 2011, 19, 5046-5052.
[138] Bolognesi, M. L.; Lizzi, F.; Perozzo, R.; Brun, R.; Cavalli, A. Synthesis of a small library
of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing
anti-trypanosomal and anti-leishmanial activity. Bioorg. Med. Chem. Lett., 2008, 18, 2272-
2276.
[139] Jiménez-Alonso, S.; Pérez-Lomas, A. L.; Estévez-Braun, A.; Martinez, F. M.; Orellana, H.
C.; Ravelo, A. G.; Gamarro, F.; Castanys, S.; López, M. Bis-pyranobenzoquinones as a
New Family of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-
Glycoprotein in Mammalian Cells and the Protozoan Parasite Leishmania. J. Med. Chem.,
2008, 51, 7132-7143.
[140] Mantyla, A.; Garnier, T.; Rautio, J.; Nevalainen, T.; Vepsalainen, J.; Koskinen, A.; Croft,
S. L.; Jarvinen, T. Synthesis, in Vitro Evaluation, and Antileishmanial Activity of Water-
Soluble Prodrugs of Buparvaquone. J. Med. Chem. 2004, 47
, 188-195.
[141] Avlonitis, N.; Lekka, E.; Detsi, A.; Koufaki, M.; Calogeropoulou, T.; Sco ulica, E.; Siapi,
E.; Kyrikou, I.; Mavromoustakos, T.; Tsotinis, A.; Grdadolnik, S. G.; Makriyannis, A.
Antileishmanial Ring-Substituted Ether Phospholipids. J. Med. Chem. 2003, 46, 755-767.
[142] Sanders, J. M.; Gomez, A. O.; Mao, J.; Meints, G. A.; Van Brussel, E. M.; Burzynska, A.;
Kafarski, P.; Gonzalez-Pacanowska, D.; Oldfield, E. 3-D QSAR Investigations of the
Inhibition of Leishmania major Farnesyl Pyrophosphate Synth ase by Bisphosphonates. J.
Med. Chem. 2003, 46, 5171-5183.
[143] Martin, M. B.; Grimley, J. S.; Lewis, J. C.; Heath III, H. T.; Bailey, B. N.; Kendrick, H.;
Yardley, V.; Caldera, A.; Lira, R.; Urbina, J. A.; Moreno, S. N. J.; Docampo, R.; Croft, S.
L.; Oldfield, E. Bisphosphonates Inhibit the Growth of Trypanosoma brucei, Trypanosoma
cruzi, Leishm ania donovani, Toxoplasma gondii, and Plasmodium falciparum: A Potential
Route to Chemotherapy. J. Med. Chem. 2001, 44, 909-916.
[144] Luque-Ortega, J. R.; Reuther, P.; Rivas, L.; Dardonville, C. New Benzophenone-Derived
Bisphosphonium Salts as Leishmanicidal Leads Targeting Mitochondria through Inhibition
of Respiratory Complex II. J. Med. Chem. 2010, 53, 17 8 8-1798.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
120 Organic Compounds to Combat Neglected Tropical Diseases Boechat and Pinheiro
[145] Saugar, J. M.; Delgado, J.; Hornillos, V.; Luque-Orteg a, J. R.; Amat-Guerri, F.; Acuña, A.
U.; Rivas, L. Synthesis and Biological Evaluation of Fluorescent Leishmanicidal
Analogues of Hexadecylphosphocholine (Miltefosine) as Probes of Antiparasite
Mechanisms. J. Med. Chem. 2007, 50, 5994-6003.
[146] Hornillos, V.; Carrillo, E.; Rivas, L.; Amat-Guerri, F.; Acuña, A. U. Synthesis of BODIPY-
labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of
miltefosine. Bioorg. Med. Chem. Lett., 2008, 18, 6336-6339.
[147] Coghi, P.; Vaiana, N.; Pezzano, M. G.; Rizzi, L.; Kaiser, M.; Brun, R.; Romeo, S. Parallel
synthesis and antileishmanial activity of ether-linked phospholipids. Bioorg. Med. Chem.
Lett., 2008, 18, 4658-4660.
[148] Papanastasiou, I.; Prousis, K. C.; Georgikopoulou, K.; Pavlidis, T.; Scoulica, E.;
Kolocouris, N.; Calogeropoulou, T. Design and synthesis of new adamantyl-substituted
antileishmanial ether phospholipids. Bioorg. Med. Chem. Lett., 2010, 20, 5484-5487.
[149] Calogeropoulou, T.; Angelou, P.; Detsi, A.; Fragiadaki, I.; Scoulica, E. Design and
Synthesis of Potent Antileishmanial Cycloalkylidene-Substituted Ether Phospholipid
Derivatives. J. Med. Chem. 2008, 51, 897-908.
[150] Avery, M. A.; Muraleedharan, K. M.; Desai, P. V.; Bandyopadh yaya, A. K.; Furtado, M.
M.; Tekwani, B. L. Structure-Activity Relationships of the Antimalarial Agent Artemisinin.
8. Design, Synthesis, and CoMFA Studies toward the Development of Artemisinin-Based
Drugs against Leishmaniasis and Malaria. J. Med. Chem. 2003, 46, 4244-4258.
[151] Galal, A. M.; Gul, W.; Slade, D.; Ross, S. A.; Feng, S.; Hollingshead, M. G.; Alley, M. C.;
Kaur, G.; ElSohly, M. A. Synthesis and evaluation of dihydroartemisinin and
dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity. Bioorg.
Med. Chem., 2009, 17, 741-751.
[152] Souza, R. O. M. A.; Pereira, V. L. P.; Muzitano, M. F.; Falcão, C. A. B.; Rossi-Bergmann,
B.; Filho, E. B. A.; Vasconcellos, M. L. A. A. High selective leishmanicidal activity of 3-
hydroxy-2-methylene-3-(4-bromophenyl)propanenitrile and analogous compounds. Eur. J.
Med. Chem., 2007, 42, 99-102.
[153]
Barbosa, T. P.; Junior, C. G. L.; Silva, F. P. L.; Lopes, H. M.; Figueiredo, L. R. F.; Sousa,
S. C. O.; Batista, G. N.; Silva, T. G.; Silva, T. M. S.; Oliveira, M. R.; Vasconcellos, M. L.
A. A. Improved synthesis of seven aromatic BayliseHillman adducts (BHA): Evaluation
against Artemia salina Leach. and Leishmania chagasi. Eur. J. Med. Chem., 2009, 44,
1726-1730.
[154] Junior, C. G. L.; Assis, P. A. C.; Silva, F. P. L.; Sousa, S. C. O.; Andrade, N. G.; Barbosa,
T. P.; Neris, P. L. N.; Segundo, L. V. G.; Anjos, I. C.; Carvalho, G. A. U.; Rocha, G. B.;
Oliveira, M. R.; Vasconcellos, M. L. A. A. Efficient synthesis of 16 aromatic Morita-
Baylis-Hillman adducts : Biological evaluation on Leishmania amazonensis and
Leishmania chagasi. Bioorganic Chemistry 2010, 38, 279-284.
[155] Silva, F. P. L.; Assis, P. A. C.; Junior, C. G. L.; Andrade, N. G.; Cunha, S. M. D.; Oliveira,
M. R.; Vasconcellos, M. L. A. A. Synthesis, evaluation against Leishmania amazonensis
and cytotoxicity assays in macrophages of sixteen new congeners MoritaeBayliseHillman
adducts. Eur. J. Med. Chem., 2011, 46, 4295-4301.
[156] Barbosa, T. P.; Sousa, S. C. O.; Amorim, F. M.; Rodrigues, Y. K. S.; Assis, P. A. C.;
Caldas, J. P. A.; Oliveira, M. R.; Vasconcellos, M. L. A. A. Design, synthesis and
antileishmanial in vitro activity of new series of chalcones-like compounds: A molecular
hybridization approach. Bioorg. Med. Chem., 2011, 19, 4250-425 6.
Соседние файлы в папке Библиотека им академика М.И. Перельмана